Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072628 · ClinicalTrials.gov registry record · NA
E-cigarettes, Nicotine Inhaler, and Blood Vessel Function
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT03072628: Completed NA study, sponsored by University of California, Los Angeles.
NCT03072628 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03072628, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity
Primary Outcome
FMD is a measure of endothelial function
Interventions
- OTHER sham control
- OTHER e-cig with nicotine
- OTHER e-cig without nicotine
- OTHER nicotine inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
What the finished NCT03072628 record still lists
NCT03072628 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 4 interventions - of which sham control is the first listed.
NCT03072628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03072628 about?
NCT03072628 is a clinical study titled "E-cigarettes, Nicotine Inhaler, and Blood Vessel Function". Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity
What is the current status of trial NCT03072628?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2017-01-11. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT03072628?
The interventions under investigation include: sham control (OTHER), e-cig with nicotine (OTHER), e-cig without nicotine (OTHER), nicotine inhaler (OTHER).
Who is sponsoring clinical trial NCT03072628?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03072628's enrollment target sits among peer trials
148 702nd of 2000 higher than 1,298 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI